These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23289676)

  • 1. Introduction: the challenge of nanomedicine human subjects research: protecting participants, workers, bystanders, and the environment.
    Wolf SM
    J Law Med Ethics; 2012; 40(4):712-5. PubMed ID: 23289676
    [No Abstract]   [Full Text] [Related]  

  • 2. Recommendations for nanomedicine human subjects research oversight: an evolutionary approach for an emerging field.
    Fatehi L; Wolf SM; McCullough J; Hall R; Lawrenz F; Kahn JP; Jones C; Campbell SA; Dresser RS; Erdman AG; Haynes CL; Hoerr RA; Hogle LF; Keane MA; Khushf G; King NM; Kokkoli E; Marchant G; Maynard AD; Philbert M; Ramachandran G; Siegel RA; Wickline S
    J Law Med Ethics; 2012; 40(4):716-50. PubMed ID: 23289677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concepts of risk in nanomedicine research.
    Hogle LF
    J Law Med Ethics; 2012; 40(4):809-22. PubMed ID: 23289683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A portrait of nanomedicine and its bioethical implications.
    Hall RM; Sun T; Ferrari M
    J Law Med Ethics; 2012; 40(4):763-79. PubMed ID: 23289679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An empirical examination of the current state of publically available nanotechnology guidance materials.
    Fleege L; Lawrenz F
    J Law Med Ethics; 2012; 40(4):751-62. PubMed ID: 23289678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Building an ethical foundation for first-in-human nanotrials.
    Dresser R
    J Law Med Ethics; 2012; 40(4):802-8. PubMed ID: 23289682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responsible conduct in nanomedicine research: environmental concerns beyond the common rule.
    Resnik DB
    J Law Med Ethics; 2012; 40(4):848-55. PubMed ID: 23289687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond human subjects: risk, ethics, and clinical development of nanomedicines.
    Kimmelman J
    J Law Med Ethics; 2012; 40(4):841-7. PubMed ID: 23289686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Handling worker and third-party exposures to nanotherapeutics during clinical trials.
    Ramachandran G; Howard J; Maynard A; Philbert M
    J Law Med Ethics; 2012; 40(4):856-64. PubMed ID: 23289688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicine first-in-human research: challenges for informed consent.
    King NM
    J Law Med Ethics; 2012; 40(4):823-30. PubMed ID: 23289684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prudent precaution in clinical trials of nanomedicines.
    Marchant GE; Lindor RA
    J Law Med Ethics; 2012; 40(4):831-40. PubMed ID: 23289685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Office for Protection from Research Risks.
    Porter JP
    Kennedy Inst Ethics J; 1992 Sep; 2(3):279-82. PubMed ID: 10121091
    [No Abstract]   [Full Text] [Related]  

  • 13. Protecting vulnerable research subjects: practical realities of institutional review board review and approval.
    Wichman A
    J Health Care Law Policy; 1998; 1(1):88-104. PubMed ID: 15573431
    [No Abstract]   [Full Text] [Related]  

  • 14. In plain sight: a solution to a fundamental challenge in human research.
    Shepherd L; Riley MF
    J Law Med Ethics; 2012; 40(4):970-89. PubMed ID: 23289699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is unique about nanomedicine? The significance of the mesoscale.
    Khushf G; Siegel RA
    J Law Med Ethics; 2012; 40(4):780-94. PubMed ID: 23289680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research ethics and the EPA.
    Childress JF; Taylor MR
    Science; 2004 Dec; 306(5705):2191; author reply 2191. PubMed ID: 15622559
    [No Abstract]   [Full Text] [Related]  

  • 17. IOM report on the system for protecting human research participants.
    Beauchamp TL
    Kennedy Inst Ethics J; 2002 Dec; 12(4):389-90. PubMed ID: 12645614
    [No Abstract]   [Full Text] [Related]  

  • 18. Advance directives in dementia research: promoting autonomy and protecting subjects.
    Dresser R
    IRB; 2001; 23(1):1-6. PubMed ID: 12530449
    [No Abstract]   [Full Text] [Related]  

  • 19. Protecting patients in ongoing clinical trials.
    Shuchman M
    CMAJ; 2010 Feb; 182(2):124-6. PubMed ID: 20008507
    [No Abstract]   [Full Text] [Related]  

  • 20. Research on humans: what have we learned?
    King NM
    Forum Appl Res Public Policy; 1997; 12(3):132-6. PubMed ID: 12962102
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.